These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24113653)

  • 1. Generation and characterization of a rabbit monoclonal antibody site-specific for tau O-GlcNAcylated at serine 400.
    Cameron A; Giacomozzi B; Joyce J; Gray A; Graham D; Ousson S; Neny M; Beher D; Carlson G; O'Moore J; Shearman M; Hering H
    FEBS Lett; 2013 Nov; 587(22):3722-8. PubMed ID: 24113653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers.
    Yuzwa SA; Cheung AH; Okon M; McIntosh LP; Vocadlo DJ
    J Mol Biol; 2014 Apr; 426(8):1736-52. PubMed ID: 24444746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody.
    Yuzwa SA; Yadav AK; Skorobogatko Y; Clark T; Vosseller K; Vocadlo DJ
    Amino Acids; 2011 Mar; 40(3):857-68. PubMed ID: 20706749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of O-GlcNAc Modified Recombinant Tau in E. coli and Detection of Ser400 O-GlcNAc Tau In Vivo.
    Yuzwa SA; Vocadlo DJ
    Methods Mol Biol; 2017; 1523():237-248. PubMed ID: 27975253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy.
    Graham DL; Gray AJ; Joyce JA; Yu D; O'Moore J; Carlson GA; Shearman MS; Dellovade TL; Hering H
    Neuropharmacology; 2014 Apr; 79():307-13. PubMed ID: 24326295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAcylation modulates the self-aggregation ability of the fourth microtubule-binding repeat of tau.
    Yu CH; Si T; Wu WH; Hu J; Du JT; Zhao YF; Li YM
    Biochem Biophys Res Commun; 2008 Oct; 375(1):59-62. PubMed ID: 18671940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation.
    Smet-Nocca C; Broncel M; Wieruszeski JM; Tokarski C; Hanoulle X; Leroy A; Landrieu I; Rolando C; Lippens G; Hackenberger CP
    Mol Biosyst; 2011 May; 7(5):1420-9. PubMed ID: 21327254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The O-GlcNAc Modification of Recombinant Tau Protein and Characterization of the O-GlcNAc Pattern for Functional Study.
    El Hajjar L; Bridot C; Nguyen M; Cantrelle FX; Landrieu I; Smet-Nocca C
    Methods Mol Biol; 2024; 2754():237-269. PubMed ID: 38512671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice.
    Hastings NB; Wang X; Song L; Butts BD; Grotz D; Hargreaves R; Fred Hess J; Hong KK; Huang CR; Hyde L; Laverty M; Lee J; Levitan D; Lu SX; Maguire M; Mahadomrongkul V; McEachern EJ; Ouyang X; Rosahl TW; Selnick H; Stanton M; Terracina G; Vocadlo DJ; Wang G; Duffy JL; Parker EM; Zhang L
    Mol Neurodegener; 2017 May; 12(1):39. PubMed ID: 28521765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.
    Liu F; Iqbal K; Grundke-Iqbal I; Hart GW; Gong CX
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10804-9. PubMed ID: 15249677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAcylation: A regulator of tau pathology and neurodegeneration.
    Gong CX; Liu F; Iqbal K
    Alzheimers Dement; 2016 Oct; 12(10):1078-1089. PubMed ID: 27126545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and characterization of a site-specific antibody for SIRT1 O-GlcNAcylated at serine 549.
    Shan H; Sun J; Shi M; Liu X; Shi Z; Yu W; Gu Y
    Glycobiology; 2018 Jul; 28(7):482-487. PubMed ID: 29688431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MK-8719, a Novel and Selective
    Wang X; Li W; Marcus J; Pearson M; Song L; Smith K; Terracina G; Lee J; Hong KK; Lu SX; Hyde L; Chen SC; Kinsley D; Melchor JP; Rubins DJ; Meng X; Hostetler E; Sur C; Zhang L; Schachter JB; Hess JF; Selnick HG; Vocadlo DJ; McEachern EJ; Uslaner JM; Duffy JL; Smith SM
    J Pharmacol Exp Ther; 2020 Aug; 374(2):252-263. PubMed ID: 32493725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.
    Gatta E; Lefebvre T; Gaetani S; dos Santos M; Marrocco J; Mir AM; Cassano T; Maccari S; Nicoletti F; Mairesse J
    Pharmacol Res; 2016 Mar; 105():186-97. PubMed ID: 26816085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of Intracellular Tau Aggregation Regulated by OGA/OGT Inhibitors.
    Lim S; Haque MM; Nam G; Ryoo N; Rhim H; Kim YK
    Int J Mol Sci; 2015 Aug; 16(9):20212-24. PubMed ID: 26343633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IP-LC-MSMS Enables Identification of Three Tau
    Bijttebier S; Rodrigues Martins D; Mertens L; Grauwen K; Bruinzeel W; Willems R; Bartolomé-Nebreda JM; Theunis C; Bretteville A; Ebneth A; Dillen L
    J Proteome Res; 2023 Apr; 22(4):1309-1321. PubMed ID: 36888912
    [No Abstract]   [Full Text] [Related]  

  • 17. Synapsin-1 and tau reciprocal O-GlcNAcylation and phosphorylation sites in mouse brain synaptosomes.
    Kang MJ; Kim C; Jeong H; Cho BK; Ryou AL; Hwang D; Mook-Jung I; Yi EC
    Exp Mol Med; 2013 Jun; 45(6):e29. PubMed ID: 23807304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semi-synthesis of a tag-free O-GlcNAcylated tau protein by sequential chemoselective ligation.
    Schwagerus S; Reimann O; Despres C; Smet-Nocca C; Hackenberger CP
    J Pept Sci; 2016 May; 22(5):327-33. PubMed ID: 27071766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-GlcNAc modification and the tauopathies: insights from chemical biology.
    Yuzwa SA; Vocadlo DJ
    Curr Alzheimer Res; 2009 Oct; 6(5):451-4. PubMed ID: 19874270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does O-GlcNAc play a role in neurodegenerative diseases?
    Lefebvre T; Guinez C; Dehennaut V; Beseme-Dekeyser O; Morelle W; Michalski JC
    Expert Rev Proteomics; 2005 Apr; 2(2):265-75. PubMed ID: 15892570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.